Effects of glycemic control and other determinants on vascular disease in type 2 diabetes
- 1 October 2002
- journal article
- conference paper
- Published by Elsevier in The American Journal of Medicine
- Vol. 113 (6) , 12-22
- https://doi.org/10.1016/s0002-9343(02)01277-9
Abstract
No abstract availableThis publication has 63 references indexed in Scilit:
- Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational studyBMJ, 2000
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial InfarctionNew England Journal of Medicine, 1998
- Induction of Hyperinsulinemia Combined With Hyperglycemia and Hypertriglyceridemia Increases Plasminogen Activator Inhibitor 1 in Blood in Normal Human SubjectsDiabetes, 1998
- Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitusBMJ, 1997
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- George Lyman Duff Memorial Lecture. Atherogenesis in diabetes.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Diabetes and atherosclerosis: An epidemiologic viewDiabetes/Metabolism Research and Reviews, 1987
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- Fibrinopeptide-A in Diabetes Mellitus: Relation to Levels of Blood Glucose, Fibrinogen Disappearance, and Hemodynamic ChangesDiabetes, 1985